SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Sonoma Pharmaceuticals, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.12+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $4.31M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 7, 2024(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Aug 30, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jun 20, 2019 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Jun 19, 2019 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Jun 30, 2016 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Jun 27, 2016 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Jun 25, 2013(first seen in filings) | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Apr 1, 2013 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |